Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 14, 2011

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Complera New Drug Initial Review Require Prior Approval Prior Approval Required
Brilinta New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Edarbi New Drug Initial Review Require Prior Approval Prior Approval Required
Daliresp New Drug Initial Review Require Prior Approval Prior Approval Required
Pradaxa New Drug Appeal Require Prior Approval Prior Approval Required
Incivek New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Latuda New Drug Appeal Remove Prior Approval Requirement Prior Approval Required
Exelon Patch PDL Appeal Remove Prior Approval Requirement Prior Approval Required